Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2025)

ENDRA Life Sciences has reported Other Non-Current Assets over the past 2 years, most recently at $5986.0 for Q4 2021.

  • Quarterly Other Non-Current Assets changed 0.0% to $5986.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $5986.0 through Dec 2021, changed 0.0% year-over-year, with the annual reading at $5986.0 for FY2021, 0.0% changed from the prior year.
  • Other Non-Current Assets was $5986.0 for Q4 2021 at ENDRA Life Sciences, roughly flat from $5986.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $5986.0 in Q4 2020 and troughed at $5986.0 in Q4 2020.